GYRE
USDGyre Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$7.470
Максимум
$7.470
Минимум
$7.250
Объем
0.06M
Фундаментальные показатели компании
Рыночная капитализация
662.1M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.09M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems
Jefferies Initiates Coverage On Gyre Therapeutics with Buy Rating, Announces Price Target of $16
Jefferies analyst Roger Song initiates coverage on Gyre Therapeutics with a Buy rating and announces Price Target of $16.
Связанные акции
VRTX
Vertex Pharmaceuticals Incorporated
RILYP
B. Riley Financial Inc. Depositary Shares each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred Stock
TMHC
Taylor Morrison Home Corporation
CSX
CSX Corporation
TNET
TriNet Group Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.